(Q85067257)

English

Radiographic regression of vestibular schwannomas induced by bevacizumab treatment: sustain under continuous drug application and rebound after drug discontinuation

scientific article published on September 22, 2010

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20860987%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Radiographic regression of vestibular schwannomas induced by bevacizumab treatment: sustain under continuous drug application and rebound after drug discontinuation (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20860987%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference

based on heuristic

inferred from title

author name string

V-F Mautner

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20860987%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

R. Nguyen

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20860987

18 July 2024

R. Knecht

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20860987

18 July 2024

C. Bokemeyer

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20860987

18 July 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20860987

18 July 2024

publication date

22 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20860987%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

full work available at URL

https://doi.org/10.1093/annonc/mdq566

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20860987

18 July 2024

http://annonc.oxfordjournals.org/cgi/content/abstract/21/11/2294

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20860987

18 July 2024

https://api.elsevier.com/content/article/PII:S0923753419395547?httpAccept=text/xml

1 reference

10.1093/ANNONC/MDQ566

https://api.crossref.org/works/10.1093/ANNONC/MDQ566

18 July 2024

https://api.elsevier.com/content/article/PII:S0923753419395547?httpAccept=text/plain

1 reference

10.1093/ANNONC/MDQ566

https://api.crossref.org/works/10.1093/ANNONC/MDQ566

18 July 2024

http://academic.oup.com/annonc/article-pdf/21/11/2294/576294/mdq566.pdf

1 reference

10.1093/ANNONC/MDQ566

https://api.crossref.org/works/10.1093/ANNONC/MDQ566

18 July 2024

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20860987%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20860987%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20860987%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

2294-2295

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20860987%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Bevacizumab induces regression of vestibular schwannomas in patients with neurofibromatosis type 2

1

1 reference

10.1093/ANNONC/MDQ566

https://api.crossref.org/works/10.1093/ANNONC/MDQ566

18 July 2024

Hearing improvement after bevacizumab in patients with neurofibromatosis type 2

2

1 reference

10.1093/ANNONC/MDQ566

https://api.crossref.org/works/10.1093/ANNONC/MDQ566

18 July 2024

Incidence and risk of significantly raised blood pressure in cancer patients treated with bevacizumab: an updated meta-analysis

3

1 reference

10.1093/ANNONC/MDQ566

https://api.crossref.org/works/10.1093/ANNONC/MDQ566

18 July 2024

Clinical pharmacokinetics of bevacizumab in patients with solid tumors

4

1 reference

10.1093/ANNONC/MDQ566

https://api.crossref.org/works/10.1093/ANNONC/MDQ566

18 July 2024

Identifiers

10.1093/ANNONC/MDQ566

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20860987%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20860987%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q85067257&oldid=2213253304"